Machine Learning to mRNA: How I Built a Personalised Cancer Vaccine for My Dog

Brief bio Paul Conyngham is the founder of Gamgee, a Y Combinator company developing personalised mRNA cancer vaccines for dogs. After 17 years in machine learning, Paul taught himself genomics and used AI to design a personalised vaccine for his dog Rosie, whose responsive tumours shrank by 50–75%. Talk outline \- Rosie’s cancer and why existing treatments were not enough \- Using AI to cross from machine learning into genomics \- The journey from tumour sequencing to an administered mRNA vaccine \- What worked\, what failed and what one patient can teach us \- Turning a year\-long manual process into repeatable software \- Why Gamgee is starting with dogs and where the technology goes next NOTE: Register for this event here : https://www.meetup.com/data-science-sydney/events/316413053